Skip to content

Erector Spinae Plane Block Versus Classic Epidural Analgesia in Labor

Lumbar Erector Spinae Plane Block Versus Classic Epidural Analgesia in Labor

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04776512
Enrollment
50
Registered
2021-03-01
Start date
2021-03-01
Completion date
2021-07-31
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia in Labor

Keywords

analgesia, vaginal delivery, ESP, EPIDURAL

Brief summary

Prosepective,Randomized, controlled study enrolling full termed parturients admitted for vaginal delivery. At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups: * ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the level of the 3 rd Lumbar transverse process. * Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural analgesia.

Detailed description

Prosepective,Randomized, controlled study enrolling full termed parturients admitted for vaginal delivery. At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups: * ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the level of the 3 rd Lumbar transverse process. * Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural analgesia. For the first group: 20 ml of 0,375% isobaric Bupivacain solution will be injected bilaterally under ultrasound direct vision. Concerning the second group, patients will have a continuous injection of 0,125% Bupivacain solution associated to 0,25 mcg of Sufentanil/ml through an epidural catheter in the L3-L4 or L4-L5 intervertebral space. For the 2 groups, analgesia will be assessed during all the labor period hourly using the Visual Analog pain Score (VAS).

Interventions

PROCEDUREESP Block With Bupivacain

bilateral lumbar ESP block using 0.375% Bupivacain

PROCEDUREEpidural Analgesia

Continuous Lumbar Epidural analgesia With 0,125% Bupivacain+0,25 mcg/ml Sufentanil

Sponsors

Mongi Slim Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Full termed parturients admitted for vaginal delivery * singleton pregnancy * No contraindications to perimedullar analgesia techniques

Exclusion criteria

* Indication to Cesarean section during labor period

Design outcomes

Primary

MeasureTime frameDescription
Analgesia during laborchange in VAS score 1 hour after the beginning of laboranalgesia assessed using VAScore

Contacts

Primary ContactMhamed Sami Mebazaa, Professor
msmebazaa@gamil.com0021622252589
Backup ContactBen Souissi Asma, As professor
bsouissiasma@gamil.com0021698336883

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026